Ad is loading...
ATEYX
Price
$174.27
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
NPFCX
Price
$60.82
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

ATEYX vs NPFCX

Header iconATEYX vs NPFCX Comparison
Open Charts ATEYX vs NPFCXBanner chart's image
AB Sustainable Global Thematic Advisor
Price$174.27
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective C
Price$60.82
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ATEYX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ATEYX vs. NPFCX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEYX is a Buy and NPFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 143B vs. ATEYX (1.82B). ATEYX pays higher dividends than NPFCX: ATEYX (0.22) vs NPFCX (0.20). ATEYX was incepted earlier than NPFCX: ATEYX (28 years) vs NPFCX (24 years). ATEYX is a more actively managed with annual turnover of: 42.00 vs. NPFCX (17.00). ATEYX has a lower initial minimum investment than NPFCX: ATEYX (0) vs NPFCX (250). ATEYX (16.89) and NPFCX (16.81) have marching annual gain over last year. NPFCX (36.67) and ATEYX (36.21) have equivalent 5 years return.
ATEYXNPFCXATEYX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD10.13716.11363%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B143B1%
Annual Yield % from dividends0.220.20109%
Returns for 1 year16.8916.81100%
Returns for 3 years-16.33-9.89165%
Returns for 5 years36.2136.6799%
Returns for 10 years100.0960.23166%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRGP207.694.85
+2.39%
Targa Resources Corp
PZG0.380.01
+1.34%
Paramount Gold Nevada Corp
PEBO35.230.44
+1.26%
Peoples Bancorp
GMS99.100.80
+0.81%
GMS
FATE2.07-0.15
-6.76%
Fate Therapeutics